USA-based Kailera Therapeutics today announced its launch as a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of next-generation therapies for the treatment of obesity and related conditions. 1 October 2024
Paris-based asset manager Kurma Partners has raised 140 million euros ($154 million), successfully completing the first closing of Biofund IV 4 October 2024
Caliway Biopharmaceuticals has successfully completed its initial public offering, raising NT$6.4 billion ($206 million), the largest IPO in Taiwan's biotech industry to date. 3 October 2024
Shares of UK drug developer Hemogenyx Pharmaceuticals rose as much as 9% and closed up 5.9% at 1.70 pence yesterday on the news of a further investment from Prevail Partners. 3 October 2024
UK-based biotech Resolution Therapeutics has announced the completion of a £63.5 million ($76.8 million) series B financing round led by Syncona. 3 October 2024
UK-based biotech LoQus23 Therapeutics has closed a £35 million ($43 million) series A financing round, led by Forbion, with support from SV Health Investors' Dementia Discovery Fund and Novartis Venture Fund. 2 October 2024
USA-based Kailera Therapeutics today announced its launch as a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of next-generation therapies for the treatment of obesity and related conditions. 1 October 2024
Boston, USA-based biotech Aktis Oncology, which is targeting alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced the successful closing of an oversubscribed and upsized $175 million Series B financing. 1 October 2024
Chicago, USA-based ARCH Venture Partners revealed it has closed the ARCH Venture Fund XIII, a venture capital fund with more than $3 billion to support the founding and growth of early-stage biotechnology companies. 27 September 2024
USA-based biotech funder and incubator Flagship Pioneering yesterday unveiled Mirai Bio, a company pioneering the first open end-to-end platform for the biotech industry to enable the co-creation of fully optimized genetic medicines. 27 September 2024
The UK government has released a position paper outlining its vision for Framework Programme 10 (FP10), a successor to Horizon Europe, the EU's flagship research collaboration program. 26 September 2024
Italian biotech Genespire—which is developing off-the-shelf gene therapies for pediatric patients affected by genetic diseases—has announced the closing of a 46.6 million euros ($52 million) Series B financing. 25 September 2024
Healthcare plan provider Centivo has raised $75 million in equity and debt financing to support its goal of offering affordable care to employees and their families. 25 September 2024
Rare disease firm bluebird bio has announced a company-wide restructuring aimed at cutting costs by 20% and achieving quarterly cash flow break-even by the second half of 2025. 25 September 2024
Aptadir Therapeutics, a biotech company focused on RNA inhibitor-based therapies for cancer and genetic conditions, has launched with $1.6 million in pre-seed funding. 24 September 2024
Australian biotech company Telix Pharmaceuticals is to acquire USA-based RLS Radiopharmacies, expanding its manufacturing and distribution footprint in North America. 24 September 2024
British biotech Vicebio has secured $100 million in a series B funding round to accelerate the development of its next-generation vaccines against respiratory viruses. 23 September 2024
Californian investment group Westlake Village BioPartners has launched two new funds totaling $500 million, with the goal of promoting promising firms with innovative technologies. 15 December 2020
Beijing’s Sinovac Biotech has secured approximately $500 million in funding for further development, capacity expansion and manufacturing of its coronavirus vaccine. 8 December 2020
MaaT Pharma has secured an additional 7.35 million euros ($8.7 million) in an extension of its Series B financing, bringing the total raised in this round to 25.35 million euros. 1 December 2020
Privately-held Scottish biotech ILC Therapeutics has secured an investment from Medical Incubator Japan, a Tokyo-based fund specializing in healthcare. 1 December 2020
Life sciences investment trust Syncona has announced the foundation of a new Syncona company, Purespring Therapeutics, with a £45.0 million ($59.5 million) Series A financing. 21 November 2020
Celgene-backed Chinese biotech Antengene had an initial public offering (IPO) in Hong Kong’s HKEX today (November 20). The Shanghai-based clinical -stage biotech, which develops small molecules and antibodies, raised HK$ 2.63 billion ($400 million) to speed up its further development. 20 November 2020
Newly-formed Ireland-based SynOx Therapeutics, a clinical stage biopharmaceutical company, today announced the closing of a 37 million euros ($44 million) Series A financing co-led by HealthCap and Medicxi and joined by investors Forbion and Gimv. 19 November 2020
CNS disease specialist Synendos Therapeutics has raised 20 million Swiss francs ($22 million) in a series A financing round co-led by Kurma Partners and Sunstone Life Science Ventures. 12 November 2020
Private equity (PE) investors are betting big on Indian drug makers, especially those that manufacture active pharmaceutical ingredients (APIs), with investments jumping more than fourfold so far this year. 11 November 2020
USA-based Locus Biosciences, a biotech developing CRISPR-enhanced precision antibacterial products, has announced a $12.5 billion partnership with Combatting Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) that takes its total investment pledges since the start of 2019 close to $1 billion. 10 November 2020
As the coronavirus pandemic continues, the previously out-of-favor global biotech and life sciences sector is seeing significant investment and a reputational boost, writes Maxim Jacobs, managing partner and director of research at Edison Investment Research, in an Expert View. 4 November 2020
US clinical-stage biotech Scholar Rock skyrocketed 119% by close of trading Tuesday and was up a further 13.9% to $34.16 this morning, after it released stunning trial results on its lead investigational drug SRK-015 and announced a public offering of shares. 28 October 2020
With an essential role in the health and well-being of societies, the pharmaceutical industry has long attracted robust levels of capital, matching the high cost of cutting edge R&D and the eventual returns on investment. 28 October 2020
Canada-based biotech firm Medicago, a subsidiary of Mitsubishi Tanabe Pharma, has reached an agreement with the Canadian government to develop its COVID-19 candidate. 26 October 2020
Antibiotics accelerator CARB-X is awarding up to $3.9 million to privately-held Cellics Therapeutics to develop a new treatment for sepsis caused by drug-resistant Gram-positive and Gram-negative bacteria. 21 October 2020
US clinical-stage Aptinyx biotech said yesterday that it intends to offer and sell 12,000,000 shares of its common stock in an underwritten public offering. 21 October 2020
Privately-held US biopharma company Synspira Therapeutics today announced that the Cystic Fibrosis Foundation has made equity and structured investments in the company of up to $14 million in additional funding. 20 October 2020
Mubadala Investment Company, Abu Dhabi’s strategic investment arm, and Novo Holdings, are investing 250 million euros ($295 million) in German drug discovery and development firm Evotec, whose shares were up 2.3% at 23.06 euros by mid-morning. 13 October 2020
A pre-clinical stage biopharmaceutical group developing new medicines and treatments to treat blood and autoimmune disease and to bring the curative power of bone marrow transplantation to a greater number of patients suffering from otherwise incurable life-threatening diseases.
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news